Tandem Diabetes Care announced today that it launched its next-generation Control-IQ+ automated insulin delivery algorithm in ...

Tandem Diabetes launches Control-IQ+ technology commercially in the United States. Control-IQ+ is compatible with t:slim X2 ...

Hybrid closed-loop insulin delivery lowers risk for hypoglycemic coma and increases rate of ketoacidosis for young people with T1D.

A study with the involvement of the German Center for Diabetes Research showed that hybrid closed-loop systems offer improved long-term blood sugar values (HbA 1c levels) and a lower risk of ...

Tandem Diabetes (TNDM) announced the United States commercial launch of Control-IQ+ technology, the latest generation of the company’s advanced ...

Tandem Diabetes Care, Inc. (Nasdaq: TNDM), a leading insulin delivery and diabetes technology company, today announced the ...

People using a hybrid closed-loop system are more likely to have better HbA1c levels than those using open-loop therapies, a new study has indicated. Researchers from the German Center for Diabetes ...

New research from Washington State University in collaboration with five other institutions suggests that automated insulin ...

A study with the involvement of the German Center for Diabetes Research showed that hybrid closed-loop systems offer improved long-term blood sugar values (HbA1c levels) and a lower risk of ...

Hybrid closed-loop insulin delivery does not affect rate of severe hypoglycemia and increases rate of ketoacidosis. HealthDay News — For young people with type 1 diabetes, hybrid closed-loop ...